MYCN-induced nucleolar stress drives an early senescence-like transcriptional program in hTERT-immortalized RPE cells
Abstract MYCN is an oncogenic driver in neural crest-derived neuroblastoma and medulloblastoma. To better understand the early effects of MYCN activation in a neural-crest lineage context, we profiled the transcriptome of immortalized human retina pigment epithelial cells with inducible MYCN activat...
Enregistré dans:
Auteurs principaux: | Sofia Zanotti, Suzanne Vanhauwaert, Christophe Van Neste, Volodimir Olexiouk, Jolien Van Laere, Marlies Verschuuren, Joni Van der Meulen, Liselot M. Mus, Kaat Durinck, Laurentijn Tilleman, Dieter Deforce, Filip Van Nieuwerburgh, Michael D. Hogarty, Bieke Decaesteker, Winnok H. De Vos, Frank Speleman |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/867372e4c7ba46fb8fbf180861fa84ee |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets
par: Bieke Decaesteker, et autres
Publié: (2018) -
STR profiling and Copy Number Variation analysis on single, preserved cells using current Whole Genome Amplification methods
par: Ann-Sophie Vander Plaetsen, et autres
Publié: (2017) -
Performance of four modern whole genome amplification methods for copy number variant detection in single cells
par: Lieselot Deleye, et autres
Publié: (2017) -
MYCN amplification and ATRX mutations are incompatible in neuroblastoma
par: Maged Zeineldin, et autres
Publié: (2020) -
An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stability
par: Zsuzsanna Nagy, et autres
Publié: (2021)